Pulmonx Corporation Common Stock (LUNG) — Analysis Summary
Pulmonx Corporation Common Stock (LUNG) has a market cap of $59.98M with year-over-year revenue growth of +8.0%. Net margin stands at -59.7%. The stock trades at a P/E ratio of -1.1.
Key Takeaways
- Revenue changed +8.0% year-over-year
- Net margin of -59.7%
- P/E ratio of -1.1
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, LUNG posted revenue growth of +8.0% and trades at a P/E of -1.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.